Luguang Luo
Roger Williams Hospital, Charter Care-Prospect RI LLC
USA
Biography
Luguang Luo has been trained by medical physician and molecular biology background (Umass Medical Center and Brown Medical School USA) for more than 30 years. He initiated his career with senior outstanding endocrinologist Dr. Ivor Jackson at Brown Medical School. Dr. Luo’s significant contribution is to identify Thyrotropine Releasing Hormone (TRH) expression in pancreatic β-cell and may contribute β-cell regeneration. Since he became independent investigator, he collaborates with Dr. Quesenberry, experts in hematology, his efforts have been focusing bone marrow stem cells and diabetes and published more than 50 articles in peer reviewed Journals and about 100 abstracts presentations in American Diabetes Association Annual Meeting and Endocrine Association Annual meeting and others which lead him to receive numerous funds from JDRF, NIH and local hospitals. Recently, Dr. Luo focuses on to establish a microenvironment in retaining a balance of β-cell apoptosis and regeneration, resulting in the support of pancreatic β-cell survival and function while developing bioengineering approach to create immunorejection free human islet tissue. Dr. Luo is a Director of stem cell and diabetes Research Center in Roger William Hospital and professor affiliated with BU and Brown Medical schools. Dr. Luo is a reviewer in NIH study section and cNSF and has also been invited to review articles for numerous Journals such as Molecular Endocrinology, Journal of Neurology, Endocrinology, et al and Editor Board members.
Abstract
Abstract : The advantage of bioengineering and stem cell approach for immunorejection free human islet
Speaker Presentations